Application of bioactivity database of Chinese herbal medicine on the therapeutic prediction, drug development, and safety evaluation

Journal of Ethnopharmacology

Volumn 132, Issue 2, 2010, Pages 429-437

  Cheng, Hui Man ^a   Li, Chia Cheng ^a   Chen, Calvin Yu Chian ^a   Lo, Hsin Yi ^a   Cheng, Wen Yu ^a   Lee, Chang Hsien ^a   Yang, Shi Zhe ^a,b   Wu, Shih Lu ^a   Hsiang, Chien Yun ^a   Ho, Tin Yun ^a,b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chinese herbs; DNA microarray; Formulae; Transcriptomic

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CHUAN CHIONG CHAA TYAU SAAN; CYTOCHROME P450; DWU HWO JIH SHENG TANG; FULVESTRANT; GE GEN TANG; GELDANAMYCIN; GLUTATHIONE TRANSFERASE; GLYCOSYLTRANSFERASE; GUI ZHI TANG; HERBACEOUS AGENT; ILOPROST; JIA WEY SHIAU YAU SAAN; LIOW WEY DIYH HUANG WAN; MA XING SHI GAN TANG; RAPAMYCIN; RESVERATROL; SHIN YI CHING FEY TANG; SHO SEIRYU TO; SHU JING HWO SHIEE TANG; STAUROSPORINE; SULINDAC SULFONE; TRANSCRIPTOME; TRICHOSTATIN A; UNCLASSIFIED DRUG; UNINDEXED DRUG; WU LING SAAN; XIAO CHAI HU TANG; YIN CHEN HAO TANG; YN CHYAU SAAN; ZHU LING TANG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CHINESE HERB; CONTROLLED STUDY; DATA BASE; DNA MICROARRAY; DRUG ACTIVITY; DRUG SAFETY; DRUG SCREENING; ETHNOPHARMACOLOGY; GENE EXPRESSION PROFILING; GLUTATHIONE METABOLISM; HERBAL MEDICINE; MOUSE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; DATABASES, FACTUAL; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; KIDNEY; LIVER; METABOLIC NETWORKS AND PATHWAYS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

MUS;

EID: 78049381533     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.08.022     Document Type: Article

References (46)

1. Altenhein B., Becker A., Busold C., Beckmann B., Hoheisel J.D., Technau G.M. Expression profiling of glial genes during Drosophila embryogenesis. Developmental Biology 2006, 296:545-560.
2. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews. Drug Discovery 2006, 5:493-506.
3. Becker K.G., Barnes K.C., Bright T.J., Wang S.A. The genetic association database. Nature Genetics 2004, 36:431-432.
4. Bernhardt R. Cytochromes P450 as versatile biocatalysts. Journal of Biotechnology 2006, 124:128-145.
5. Bild A.H., Yao G., Chang J.T., Wang Q., Potti A., Chasse D., Joshi M.B., Harpole D., Lancaster J.M., Berchuck A., Olson J.A., Marks J.R., Dressman H.K., West M., Nevins J.R. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006, 439:353-357.
6. Bonham M., Arnold H., Montgomery B., Nelson P.S. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma. Cancer Research 2002, 62:3920-3924.
7. Cheng W.Y., Hsiang C.Y., Bau D.T., Chen J.C., Shen W.S., Li C.C., Lo H.Y., Wu S.L., Chiang S.Y., Ho T.Y. Microarray analysis of vanillin-regulated gene expression profile in human hepatocarcinoma cells. Pharmacological Research 2007, 56:474-482.
8. Cheng W.Y., Lien J.C., Hsiang C.Y., Wu S.L., Li C.C., Lo H.Y., Chen J.C., Chiang S.Y., Liang J.A., Ho T.Y. Comprehensive evaluation of a novel nuclear factor-κB inhibitor, quinoclamine, by transcriptomic analysis. British Journal of Pharmacology 2009, 157:746-756.
9. Cheng W.Y., Wu S.L., Hsiang C.Y., Li C.C., Lai T.Y., Lo H.Y., Shen W.S., Lee C.H., Chen J.C., Wu H.C., Ho T.Y. Relationship between San-Huang-Xie-Xin-Tang and its herbal components on the gene expression profiles in HepG2 cells. American Journal of Chinese Medicine 2008, 36:783-797.
10. Chia S., Gradishar W. Fulvestrant: expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancer. Breast 2008, 17:S16-S21.
11. DiPaola R.S., Zhang H., Lambert G.H., Meeker R., Licitra E., Rafi M.M., Zhu B.T., Spaulding H., Goodin S., Toledano M.B., Hait W.N., Gallo M.A. Clinical and biological activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. New England Journal of Medicine 1998, 339:785-791.
12. Draghici S., Khatri P., Eklund A.C., Szallasi Z. Reliability and reproducibility issues in DNA microarray measurements. Trends in Genetics 2006, 22:101-109.
13. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:14863-14868.
14. Elbarbry F.A., Marfleet T., Shoker A.S. Drug-drug interactions with immunosuppressive agents: review of the in vitro functional assays and role of cytochrome P450 enzymes. Transplantation 2008, 85:1222-1229.
15. Ganter B., Tugendreich S., Pearson C.I., Ayanoglu E., Baumhueter S., Bostian K.A., Brady L., Browne L.J., Calvin J.T., Day G.J., Breckenridge N., Dunlea S., Eynon B.P., Furness L.M., Ferng J., Fielden M.R., Fujimoto S.Y., Gong L., Hu C., Idury R., Judo M.S.B., Kolaja K.L., Lee M.D., McSorley C., Minor J.M., Nair R.V., Natsoulis G., Nguyen P., Nicholson S.M., Pham H., Roter A.H., Sun D., Tan S., Thode S., Tolley A.M., Vladimirova A., Yang J., Zhou Z., Jarnagin K. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. Journal of Biotechnology 2005, 119:219-244.
16. Ghanim H., Garg R., Aljada A., Mohanty P., Kumbkarni Y., Assian E., Hamouda W., Dandona P. Suppression of nuclear factor-κB and stimulation of inhibitor κB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. Journal of Clinical Endocrinology and Metabolism 2001, 86:1306-1312.
17. Gunther E.C., Stone D.J., Gerwien R.W., Bento P., Heyes M.P. Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:9608-9613.
18. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases. Annual Review of Pharmacology and Toxicology 2005, 45:51-88.
19. Hayes K.R., Vollrath A.L., Zastrow G.M., McMillan B.J., Craven M., Jovanovich S., Rank D.R., Penn S., Walisser J.A., Reddy J.K., Thomas R.S., Bradfield C.A. EDGE: a centralized resource for the comparison, analysis, and distribution of toxicogenomic information. Molecular Pharmacology 2005, 67:1360-1368.
20. Hsiang C.Y., Chen Y.S., Ho T.Y. Nuclear factor-κB bioluminescence imaging-guided transcriptomic analysis for the assessment of hoist-biomaterial interaction in vivo. Biomaterials 2009, 30:3042-3049.
21. Ioannides C. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 2002, 32:451-478.
22. Ishikawa T., Funahashi T., Kudo J. Effectiveness of the Kampo kami-shoyo-san (TJ-24) for tremor of antipsychotic-induced Parkinsonism. Psychiatry and Clinical Neurosciences 2000, 54:579-582.
23. Jong T.T., Lee M.R., Hsiao S.S., Hsai J.L., Wu T.S., Chiang S.T., Cai S.Q. Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2003, 33:831-837.
24. Kurokawa M, Tsurita M., Brown J., Fukuda Y., Shiraki K. Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in mice. Antiviral Research 2002, 56:183-188.
25. Lamb J. The Connectivity Map: a new tool for biomedical research. Nature Review 2007, 7:54-60.
26. Lamb J., Crawford E.D., Peck D., Modell J.W., Blat I.C., Wrobel M.J., Lerner J., Brunet J.P., Subramanian A., Ross K.N., Reich M., Hieronymus H., Wei G., Armstrong S.A., Haggarty S.J., Clemons P.A., Wei R., Carr S.A., Lander E.S., Golub T.R. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313:1929-1935.
27. Margis R., Dunand C., Teixeira F.K., Margis-Pinheiro M. Glutathione peroxidase family-an evolutionary overview. FEBS Journal 2008, 275:3959-3970.
28. Morelon E., Mamzer-Bruneel M.F., Peraldi M.N., Kreis H. Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation. Nephrology, Dialysis, Transplantation 2001, 16:18-20.
29. Muraoka K., Yoshida S., Hasegawa K., Nakanishi N., Fukuzawa I., Tomita A., Cyong J.C. A pharmacologic study on the mechanism of action of Kakkon-to: body temperature elevation and phagocytic activation of macrophages in dogs. Journal of Alternative and Complementary Medicine 2004, 10:841-849.
30. Murayama T., Yamaguchi N., Iwamoto K., Eizuru Y. Inhibition of ganciclovir-resistant human cytomegalovirus replication by Kampo (Japanese herbal medicine). Antiviral Chemistry and Chemotherapy 2006, 17:11-16.
31. Nagai T., Yamada H. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "sho-seiryu-to" -stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice. Immunopharmacology and Immunotoxicology 1998, 20:267-281.
32. Ohnuma T., Komatsu T., Nakayama S., Nishiyama T., Ogura K., Hiratsuka A. Induction of antioxidant and phase 2 drug-metabolizing enzymes by falcarindiol isolated from Notopterygium incisum extract, which activates the Nrf2/ARE pathway, leads to cytoprotection against oxidative and electrophilic stress. Archives of Biochemistry and Biophysics 2009, 488:34-41.
33. Ouzzine M., Barré L., Netter P., Magdalou J., Fournel-Gigleux S. The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation. Drug Metabolism Review 2003, 35:287-303.
34. Pharmacopoeia Commission of People's Republic of China (ChPC), 2000. Pharmacopoeia of People's Republic of China (ChP), vol. 1. Chemical Industry Press, Beijing.
35. Pittman J., Huang E., Dressman H., Horng C.F., Cheng S.H., Tsou M.H., Chen C.M., Bild A., Iversen E.S., Huang A.T., Nevins J.R., West M. Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:8431-8436.
36. Purcell A.W., Elliott T. Molecular machinations of the MHC-I peptide loading complex. Current Opinion in Immunology 2008, 20:75-81.
37. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270:467-470.
38. Sharp S., Workman P. Inhibitors of the HSP90 molecular chaperone: current status. Advances in Cancer Research 2006, 95:323-348.
39. Sievers C., Schneider H.J., Stalla G.K. Insulin-like growth factor-1 in plasma and brain: regulation in health and disease. Frontiers in Bioscience 2008, 13:85-99.
40. Smyth, G.K., 2005. Limma: linear models for microarray data. In: Gentleman, R., Carey, V., Dudoit, S., Irizarry, R., Huber, W. (Eds.), Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Springer Science and Business Media Inc. New York, pp. 397-420.
41. Stepczynska A., Lauber K., Engels I.H., Janssen O., Kabelitz D., Wesselborg S., Schulze-Osthoff K. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene 2001, 20:1193-1202.
42. Su S.Y., Hsieh C.L., Wu S.L., Cheng W.Y., Li C.C., Lo H.Y., Ho T.Y., Hsiang C.Y. Transcriptomic analysis of EGb 761-regulated neuroactive receptor pathway in vivo. Journal of Ethnopharmacology 2009, 123:68-73.
43. Tang J.C., Zhang J.N., Wu Y.T., Li Z.X. Effect of the water extract and ethanol extract from traditional Chinese medicines Angelica sinensis (Oliv.) Diels, Ligusticum chuanxiong Hort. and Rheum palmatum L. on rat liver cytochrome P450 activity. Phytotherapy Research 2006, 20:1046-1051.
44. Thomas R.S., Rank D.R., Penn S.G., Zastrow G.M., Hayes K.R., Pande K., Glover E., Silander T., Craven M.W., Reddy J.K., Jovanovich S.B., Bradfield C.A. Identification of toxicologically predictive gene sets using cDNA microarrays. Molecular Pharmacology 2001, 60:1189-1194.
45. Tutau F., Rodríguez-Ortigosa C., Puche J.E., Juanarena N., Monreal I., García Fernández M., Clavijo E., Castilla A., Castilla-Cortázar I. Enhanced actions of insulin-like growth factor-I and interferon-alpha co-administration in experimental cirrhosis. Liver International 2009, 29:37-46.
46. Whitfield M.L., George L.K., Grant G.D., Perou C.M. Common markers of proliferation. Nature Review of Cancer 2006, 6:99-106.